An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Exagen Inc. (XGN) to participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum, offering one-on-one meetings with investors and a fireside chat on March 20, 2024.
Positive
None.
Negative
None.
CARLSBAD, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum, which takes place virtually March 19-20, 2024. John Aballi, Exagen’s President and Chief Executive Officer, and Kamal Adawi, Exagen’s Chief Financial Officer, will participate in one-on-one meetings with investors and a fireside chat on Wednesday, March 20, at 1:30 PM ET.
About Exagen Inc. Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with the goal of improving patients’ clinical outcomes. Exagen is located in San Diego County, California.
For more information, please visit Exagen.com or follow @ExagenInc on X (formerly known as Twitter).
Contact: Ryan Douglas Exagen Inc. ir@exagen.com 760.560.1525
FAQ
When will Exagen Inc. (XGN) participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum?
Exagen Inc. (XGN) will participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 19-20, 2024.
Who will be representing Exagen Inc. (XGN) at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum?
John Aballi, President and CEO, and Kamal Adawi, CFO, will represent Exagen Inc. (XGN) at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum.
What is the timing of the fireside chat involving Exagen Inc. (XGN) at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum?
The fireside chat involving Exagen Inc. (XGN) will take place on Wednesday, March 20, at 1:30 PM ET during the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum.
exagen diagnostics, inc. is a patient focused, discovery driven, clia-certified, cap-accredited laboratory with a growing menu of proprietary, internally developed tests focusing in the area of rheumatology and autoimmune diseases. committed to personalized medicine, our avise tests are specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. for more information on our company, please visit www.exagen.com. for more information on avise testing services, please visit www.avisetest.com.